| Urethra Neoplasm studied in …STUDIED_INderived85 of 85show fewer |
|---|
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05987241Phase 2/Phase 3 · recruiting Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study · condition mapped ONTOLOGY_EXACT · 85 trials mapped (25 active) | — | — | Muscle Invasive Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07124000recruiting DESTINY-PANTUMOUR04 · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04963153Phase 1 · active not recruiting Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01352962Phase 1 · completed Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors · condition mapped ALIAS · 85 trials mapped (25 active) | — | — | Urethra Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04940299Phase 2 · active not recruiting Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07217171Phase 1 · recruiting A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas · condition mapped ONTOLOGY_EXACT · 85 trials mapped (25 active) | — | — | Urethral Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02812420early Phase 1 · active not recruiting Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02496208Phase 1 · active not recruiting Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05111574Phase 2 · active not recruiting Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery · condition mapped ONTOLOGY_EXACT · 85 trials mapped (25 active) | — | — | Urethral Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03237780Phase 2 · active not recruiting Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05756569Phase 2 · recruiting Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology · condition mapped ONTOLOGY_EXACT · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02012699recruiting Integrated Cancer Repository for Cancer Research · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00942331Phase 3 · completed Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 85 trials mapped (25 active) | — | — | Urethral Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05092958Phase 3 · active not recruiting Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03291028active not recruiting Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05969860Phase 2 · recruiting At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00479128Phase 1 · active not recruiting Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04953104Phase 2 · active not recruiting ARID1A and/or KDM6A Mutation and CXCL13 Expression · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06638931Phase 2 · recruiting Agnostic Therapy in Rare Solid Tumors · condition mapped ALIAS · 85 trials mapped (25 active) | — | — | Urethra Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03288545Phase 1/Phase 2 · terminated A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer · condition mapped ALIAS · 85 trials mapped (25 active) | — | — | Urethra Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04637594Phase 3 · active not recruiting Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05888532Phase 1/Phase 2 · recruiting 64Cu-GRIP B in Patients With Advanced Malignancies · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04848519Phase 2 · active not recruiting Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03582475Phase 1 · active not recruiting Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00082706Phase 2 · active not recruiting Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02122172Phase 2 · terminated Afatinib in Advanced Refractory Urothelial Cancer · condition mapped ALIAS · 85 trials mapped (25 active) | — | — | Distal Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03219333Phase 2 · completed A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer · condition mapped ALIAS · 85 trials mapped (25 active) | — | — | Urethra Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03513952Phase 2 · completed Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05899361NA · recruiting A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02643043NA · completed UC-GENOME: Urothelial Cancer-GENOmic Analysis to iMprove Patient Outcomes and rEsearch · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002914Phase 2 · completed Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003376Phase 3 · completed Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005644Phase 2 · completed Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00053209Phase 2 · completed Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004223Phase 2 · completed Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003701Phase 3 · completed Combination Chemotherapy in Treating Patients With Bladder Cancer · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03397394Phase 2 · terminated Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma · condition mapped ALIAS · 85 trials mapped (25 active) | — | — | Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03617913Phase 2 · completed Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02612194Phase 2 · terminated LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer · condition mapped ALIAS · 85 trials mapped (25 active) | — | — | Urethra Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01688999Phase 2 · completed Cabozantinib for Advanced Urothelial Cancer · condition mapped ALIAS · 85 trials mapped (25 active) | — | — | Urethra Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02437370Phase 1 · completed Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03934827Phase 1 · unknown MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006111Phase 2 · completed Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00478361Phase 2 · completed Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function · condition mapped ALIAS · 85 trials mapped (25 active) | — | — | Distal Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00749892Phase 2 · completed Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01846520NA · completed Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03935347Phase 2 · withdrawn Adoptive Cell Therapy With (LN-145) in Combination With Pembrolizumab in Treating Patients With Unresectable or Metastatic Transitional Cell Cancer Who Have Failed Cisplatin-Based Chemotherapy · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02178241Phase 2 · completed Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01282463Phase 2 · completed Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma · condition mapped ONTOLOGY_EXACT · 85 trials mapped (25 active) | — | — | Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01611662Phase 2 · terminated Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer · condition mapped ALIAS · 85 trials mapped (25 active) | — | — | Distal Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01191892Phase 2 · completed Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01089088Phase 2 · completed Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT) · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00900276completed Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01090466Phase 1/Phase 2 · completed Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03296306Phase 3 · unknown Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00022633Phase 2 · terminated S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00397488Phase 2 · completed Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00082719Phase 1 · completed Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01526486NA · completed Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer · condition mapped ONTOLOGY_EXACT · 85 trials mapped (25 active) | — | — | Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00407485Phase 2 · completed VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium · condition mapped ALIAS · 85 trials mapped (25 active) | — | — | Distal Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112905Phase 2 · terminated Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium · condition mapped ALIAS · 85 trials mapped (25 active) | — | — | Distal Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00471536Phase 2 · completed Pazopanib in Treating Patients With Metastatic Urothelial Cancer · condition mapped ALIAS · 85 trials mapped (25 active) | — | — | Distal Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01639521Phase 2 · withdrawn Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer · condition mapped ALIAS · 85 trials mapped (25 active) | — | — | Anterior Urethral Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003175Phase 2 · completed Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01031875Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Metastatic Urethral Cancer or Bladder Cancer That Has Relapsed or Not Responded to Treatment · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01118039Phase 2 · unknown Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002684Phase 2 · completed Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00014274Phase 2/Phase 3 · completed Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00022191Phase 3 · completed Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00072150Phase 2 · completed Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00009867Phase 2 · completed Arsenic Trioxide in Treating Patients With Urothelial Cancer · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045630Phase 2 · completed S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004856Phase 2 · terminated Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium · condition mapped ALIAS · 85 trials mapped (25 active) | — | — | Distal Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004074Phase 1 · completed Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu · condition mapped ALIAS · 85 trials mapped (25 active) | — | — | Distal Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00055835Phase 2 · completed S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00021099Phase 2 · completed Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer · condition mapped ALIAS · 85 trials mapped (25 active) | — | — | Distal Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00066612Phase 2 · completed S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00087295Phase 2 · terminated S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00080795Phase 2 · completed Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00014144Phase 2 · completed S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006026Phase 2 · completed Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006351Phase 2 · completed SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract · condition mapped CURATED_BROADER · 85 trials mapped (25 active) | — | — | Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00077688Phase 2 · completed TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Urothelium · condition mapped ALIAS · 85 trials mapped (25 active) | — | — | Urethra Neoplasm | 1 | Observed | clinicaltrials | graph → |